Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|
Series B Convertible Preferred Stock | - | 0 | |||||
Assets | |||||||
Assets Current | |||||||
Cash And Cash Equivalents At Carrying Value | 64 | 53 | |||||
Short Term Investments | 209 | 130 | |||||
Prepaid Expense And Other Assets Current | 9 | 6 | |||||
Assets Current | 282 | 188 | |||||
Property Plant And Equipment Net | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 5 | 5 | |||||
Long Term Investments | 154 | 30 | |||||
Other Assets Noncurrent | 0 | 4 | |||||
Assets | 442 | 228 | |||||
Liabilities And Stockhold… | |||||||
Liabilities Current | |||||||
Accounts Payable Current | 6 | 5 | |||||
Other Liabilities Current | 0 | 0 | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 8 | 8 | |||||
Operating Lease Liability Current | 2 | 2 | |||||
Liabilities Current | 16 | 14 | |||||
Operating Lease Liability Noncurrent | 3 | 4 | |||||
Liabilities | 19 | 18 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | 325 | |||||
Stockholders Equity | |||||||
Common Stock Value | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 625 | 24 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | 0 | |||||
Retained Earnings Accumulated Deficit | -202 | -140 | |||||
Stockholders Equity | 423 | -116 | |||||
Liabilities And Stockholders Equity | 442 | 228 | |||||
Temporary Equity Shares Authorized | - | 114 | |||||
Temporary Equity Shares Issued | - | 114 | |||||
Temporary Equity Shares Outstanding | - | 114 | |||||
Temporary Equity Liquidation Preference | - | 330 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | |||||
Common Stock Shares Authorized | 700 | 159 | |||||
Common Stock Shares Issued | 54 | 3 | |||||
Shares Outstanding | 54 | 3 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month |
|---|---|---|---|---|---|---|
| 2026 | 26.98% | 26.30% | - | - | - | - |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Seaport Therapeutics, Inc. (SPTX) — SEC Financial Statements & Analysis
Seaport Therapeutics, Inc. (SPTX) is a pharmaceutical preparations company, incorporated in DE. Seaport Therapeutics, Inc. trades on Nasdaq as: SPTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Seaport Therapeutics, Inc. reported a Debt-to-Equity ratio of 0.05x, a Price-to-Book (P/B) ratio of 1.81x (TTM), at a market cap of $765.33M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.05x
- P/B TTM
- 1.81x
- Market Cap
- $765.33M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Seaport Therapeutics, Inc. in?
Seaport Therapeutics, Inc. (SPTX) operates in the Pharmaceutical Preparations industry.
What is SPTX's market cap?
Seaport Therapeutics, Inc. (SPTX) has a market capitalization of $765.33M as of 2026-06-30.
What exchange does SPTX trade on?
Seaport Therapeutics, Inc. (SPTX) trades on the Nasdaq.
Where is Seaport Therapeutics, Inc. incorporated?
Seaport Therapeutics, Inc. is incorporated in DE.